Search results
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement...
WPRI Providence· 1 day agoMediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "< ...
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
ETF DAILY NEWS· 2 days agoRobeco Institutional Asset Management B.V. lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The fund ...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 1 week agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 4 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
BioNTech (NASDAQ:BNTX) Shares Up 6.1%
ETF DAILY NEWS· 4 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) shares shot up 6.1% during trading on Wednesday . 657,251 shares were traded during mid-day trading, an increase of 4% from the ...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 1 week agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
BioNTech (NASDAQ:BNTX) Coverage Initiated by Analysts at Evercore ISI
ETF DAILY NEWS· 2 weeks agoEvercore ISI assumed coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. TD Cowen boosted their ...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via AOL· 1 week agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
Investors Buy High Volume of BioNTech Call Options (NASDAQ:BNTX)
ETF DAILY NEWS· 4 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 2,346 call options on the stock. This is an increase ...
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
WHTC 1450 Holland· 1 week ago(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and ...